Clinical Trials Logo
  1. Home
  2. Nightmare
  3. NCT05588739

Cognitive-Behavioral Therapy for Children With Nightmares as a Mediator of Suicide Risk (COMAA) — COMAA  

Nightmare Clinical Trial

Official title:
Evaluating the Feasibility of a Cognitive-Behavioral Therapy for Children With Nightmares as a Mediator of Suicide Risk

Clinical Trial Summary

Youth suicide risk has increased 56% in the last decade, and suicide is the leading cause of preventable death in children and adolescents. Experiencing chronic nightmares doubles the risk of suicidal ideation in children and adolescents. Decades of research support that even when controlling for depression and insomnia, nightmares predict suicidality. Contemporary theories model nightmares as the mediating link between depression and suicide. Numerous studies examine the effect of nightmare-specific therapies on reducing suicide in adults, but none have examined whether nightmare therapies can reduce youth suicidality. The proposed pilot will evaluate the feasibility of the Cognitive Behavioral Therapy for Nightmares in Children paradigm (CBT-NC), recruiting and retaining children ages 6-17 who experience chronic nightmares. Utilizing a waitlist control (WL) model, participants (n=30) will be randomized after baseline assessment to either immediate treatment or a WL. Feasibility will be evaluated by examining retention through treatment (or WL) to post WL and post treatment assessments. Both groups will be evaluated before and after the treatment for suicidal ideation, sleep quality, and nightmare distress and frequency, in order to document improvements due to therapy. The proposed pilot will provide preliminary data about recruitment, retention, and allow for effect size calculations between groups. These results will be used to develop a larger treatment study that would ultimately evaluate the mediating effect of treatment for chronic nightmares on suicidality in children.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05588739
Study type Interventional
Source University of Oklahoma
Contact
Status Completed
Phase N/A
Start date September 30, 2020
Completion date June 16, 2023
View Details
See also
  Status Clinical Trial Phase
Completed NCT03532269 - Validation of the Sleep Assessment Algorithm in the Medical Application Nightly N/A
Completed NCT04776304 - Art Therapy qEEG Study for Service Members With a Traumatic Brain Injury and Posttraumatic Stress Symptoms N/A
Recruiting NCT04198142 - Psychiatric Inpatient Nightmare Treatment N/A
Completed NCT03934658 - Remote Study of NightWare for PTSD With Nightmares N/A
Not yet recruiting NCT06410118 - The DreamChanger Intervention in Combination With Imagery Rehearsal Therapy for Children's Nightmares N/A
Completed NCT04047277 - Cognitive Behavioral Therapy for Nightmares in Children N/A
Recruiting NCT05365607 - NightWare and Cardiovascular Health in Adults With PTSD N/A
Enrolling by invitation NCT04040387 - Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken) N/A
Not yet recruiting NCT06383806 - Decreasing Nightmares in Adults With Narcolepsy N/A
Recruiting NCT04529070 - Nightmare Rescripting and Rehearsal N/A
Withdrawn NCT04341987 - Treating Nightmares Among Domiciliary Patients N/A
Completed NCT03795987 - Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken) N/A
Recruiting NCT05414708 - Art Therapy and Emotional Well Being in Military Populations With Posttraumatic Stress Symptoms N/A
Enrolling by invitation NCT03828656 - NightWare Open Enrollment Study N/A
Recruiting NCT05950035 - An Efficient Treatment for Posttraumatic Injury for Firefighters N/A
Recruiting NCT06033781 - Cognitive-Behavioral Therapy for Children With Nightmares N/A
Completed NCT03831412 - Cognitive Behavioral Therapy for Insomnia vs. Exposure, Relaxation, and Rescripting Therapy N/A